|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-3.77/-4.34
|
Enterprise Value
3.94B
|
Balance Sheet |
Book Value Per Share
11.09
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
4.01M
|
Operating Revenue Per Share
0.06
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/16 00:07 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. |